Premium
The DiRECT principles: giving Type 2 diabetes remission programmes the best chance of success
Author(s) -
Hopkins M. D.,
Taylor R.,
Lean M. E. J.
Publication year - 2019
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/dme.14126
Subject(s) - medicine , diabetes mellitus , gerontology , library science , family medicine , endocrinology , computer science
In 2017, the 12-month primary outcome results of the Diabetes UK-funded Diabetes Remission Clinical Trial (DiRECT) were published, providing randomized controlled trial evidence to challenge the conventional view of Type 2 diabetes as a permanent and progressive condition. They showed, for the first time, that a three-phase integrated weight management programme, delivered within routine primary care, achieved remission of Type 2 diabetes in almost half of participants. Almost 9/10 achieved remissions if they could lose 15 kg or more [1]. The participants were very representative of those normally managed in UK primary care, within 6 years of diagnosis and not yet with serious complications or requiring insulin. This article is protected by copyright. All rights reserved.